Setting our research strategy
We exist to prevent the onset of arthritis, develop a cure for arthritis and transform the lives of those with arthritis (now and in the future) by building, applying and sharing knowledge.
In 2015 we defined our strategic focus to 2020, to make a positive and tangible change in the quality of life for people with arthritis so they can say: “I am in control, independent and recognised”.
We support research that is aimed at improving the quality of life of people with arthritis, reducing risk, measuring burden of disease and stacking the odds towards a cure. Supported research includes: basic discovery, experimental and applied research via a breadth of funding instruments, including programmatic, institutional and personal awards and a variety of types of partnership working.
Led by our senior leadership team, our board of trustees are responsible for setting the charity’s strategic direction and achieving the charity’s goals.
The board is supported by the charitable purposes committee (CPC), whose role is to consider the balance and alignment of activities to address the needs of people with arthritis and to support the charity’s horizon scanning by providing a wider external perspective and intelligence.
The CPC has three themed subcommittees across disease, treatment and health. Each subcommittee provides expert advice and intelligence to contribute to planning and developing research activities, as well as evaluating applications and recommending new awards and providing oversight of funded activities. Each subcommittee, when necessary, draws upon a college of experts for additional, specific expertise - including areas of research, methodology, policy work, implementation, lived experience of arthritis and health professional expertise. The subcommittees also utilise the expertise of the clinical study groups, fellowship expert group and patient insight network in support of these activities.